Barclays maintained an “Overweight” rating on PDD Holdings Inc. (NASDAQ:PDD) and kept a price target of $158. This decision ...

Eternal's share price surged in trade today, driven by strong volumes and a bullish outlook from Morgan Stanley ...

Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while ...

Matt Miksic from Barclays lowered the price target on Becton, Dickinson, and Company (NYSE:BDX) from $261 to $241, while ...

JPMorgan analysts increased the price target for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) stock to $500 from $450 and ...

Morgan Stanley lifted Salesforce, Inc. (NYSE:CRM)’s stock price target from $393 to $404, while maintaining an Overweight ...

InvestingPro analysis shows the company maintains a strong financial position ... JPMorgan maintained its Overweight rating for ORIC Pharmaceuticals with a $20 price target, highlighting the ...

On Wednesday, Cantor Fitzgerald reaffirmed its confidence in Surgery Partners (NASDAQ:SGRY), maintaining an Overweight stock rating with a steady price target of $36.00. Currently trading at $23. ...

Nutanix, Inc. (NASDAQ:NTNX) received a vote of confidence from Piper Sandler on May 29, as the firm raised its price target ...

The brokerage believes Eternal's leadership in both food delivery and quick commerce, along with its favorable cost structure ...

Nifty 50 is currently trading at 20.2 times one-year forward price-to-earnings ratio (PER), slightly below its five-year ...

Morgan Stanley has ascribed a price target of ₹405 for Swiggy, which implies a potential upside of 22% from Monday's closing ...